Proteostasis Therapeutics, Inc. (PTI) Reaches $3.11 After 4.00% Up Move; Ocado Group plc (LON:OCDO) Had 10 Bullish Analysts

February 15, 2018 - By Adrian Mccoy

The stock of Proteostasis Therapeutics, Inc. (NASDAQ:PTI) is a huge mover today! The stock increased 4.90% or $0.145 during the last trading session, reaching $3.105. About 150,042 shares traded. Proteostasis Therapeutics, Inc. (NASDAQ:PTI) has declined 66.87% since February 15, 2017 and is downtrending. It has underperformed by 83.57% the S&P500.The move comes after 9 months positive chart setup for the $102.82M company. It was reported on Feb, 15 by Barchart.com. We have $3.23 PT which if reached, will make NASDAQ:PTI worth $4.11M more.

Among 19 analysts covering Ocado Group Plc (LON:OCDO), 10 have Buy rating, 6 Sell and 3 Hold. Therefore 53% are positive. Ocado Group Plc had 194 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Not Rated” rating by Shore Capital on Tuesday, February 6. The stock of Ocado Group plc (LON:OCDO) has “Buy” rating given on Monday, January 22 by Peel Hunt. The rating was maintained by Morgan Stanley on Thursday, January 25 with “Overweight”. JP Morgan maintained Ocado Group plc (LON:OCDO) rating on Wednesday, June 29. JP Morgan has “Overweight” rating and GBX 476 target. The rating was maintained by Deutsche Bank with “Sell” on Tuesday, December 19. Barclays Capital maintained the stock with “Equal Weight” rating in Thursday, February 16 report. The firm has “Neutral” rating given on Friday, February 5 by BNP Paribas. The stock of Ocado Group plc (LON:OCDO) earned “Outperform” rating by Credit Suisse on Thursday, April 7. The firm earned “Conviction Buy” rating on Friday, September 22 by Goldman Sachs. Barclays Capital maintained the stock with “Equal Weight” rating in Tuesday, May 10 report. See Ocado Group plc (LON:OCDO) latest ratings:

14/02/2018 Broker: RBC Capital Markets Rating: Sector Performer Old Target: GBX 525.00 New Target: GBX 475.00 Maintain
14/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 520.00 New Target: GBX 570.00 Maintain
13/02/2018 Broker: Goldman Sachs Rating: Conviction Buy Old Target: GBX 560.00 New Target: GBX 540.00 Maintain
07/02/2018 Broker: Numis Securities Rating: Buy Old Target: GBX 600.00 New Target: GBX 600.00 Maintain
06/02/2018 Broker: Shore Capital Rating: Not Rated Maintain
07/02/2018 Broker: JP Morgan Rating: Overweight Maintain
07/02/2018 Broker: Citigroup Rating: Buy Old Target: GBX 400.00 New Target: GBX 400.00 Maintain
07/02/2018 Broker: Deutsche Bank Rating: Sell Maintain
06/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 520.00 New Target: GBX 520.00 Maintain
01/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 520.00 New Target: GBX 520.00 Maintain

Analysts await Proteostasis Therapeutics, Inc. (NASDAQ:PTI) to report earnings on March, 29. They expect $-0.65 EPS, down 71.05% or $0.27 from last year’s $-0.38 per share. After $-0.56 actual EPS reported by Proteostasis Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 16.07% negative EPS growth.

Proteostasis Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics that treat diseases caused by dysfunctional protein processing, such as cystic fibrosis. The company has market cap of $102.82 million. The Company’s lead product candidate is PTI-428, an orally bioavailable cystic fibrosis transmembrane conductance regulator modulator belonging to the amplifier class that is in Phase-I studies. It currently has negative earnings. The firm is also developing PTI-801, a corrector molecule; PTI-808, a potentiator molecule; and unfolded protein response modulators that are in preclinical development.

Ocado Group plc operates as an online grocery retailer in the United Kingdom. The company has market cap of 3.07 billion GBP. It primarily offers pet, kitchen and dining, and beauty products under the Ocado, Fetch, Sizzle, and Fabled names. It has a 2436.5 P/E ratio. The firm also engages in the development and monetization of intellectual property and technology used for the online retailing, logistics, and distribution of grocery and consumer goods.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts